Differential and state-dependent effects of the GluN2A-selective positive allosteric modulator GNE-5729 on executive functions
Johannes Lauer, Julia Poppke, Thomas Nickl-Jockschat, Daniela C. Dieterich, Markus Fendt, Samia Afzal · 2026
Read Differential and state-dependent effects of the GluN2A-selective positive allosteric modulator GNE-5729 on executive functions by Johannes Lauer, Julia Poppke, Thomas Nickl-Jockschat, Daniela C. Dieterich, Markus Fendt, Samia Afzal (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13598106.txt.
Description
Johannes Lauer and co-authors tested a drug that selectively boosts one subtype of NMDA receptor. The subtype is the GluN2A type. It is implicated in the thinking problems of many brain disorders. The drug was tested across mouse tests of working memory and flexibility. Their 2026 study asked whether help depends on how the impairment was caused and on the animal's starting point.
The drug did nothing for average performers yet lifted mice whose baseline working memory was naturally poor. It rescued deficits caused by amphetamine and by scopolamine, two drugs that disturb chemical modulation while leaving the receptor usable. It failed completely against MK-801, which physically plugs the receptor's pore, exactly as its mechanism predicts. Effects ran stronger in females, and mental flexibility did not improve at all. The authors describe a state-dependent profile: the booster helps only when the system is underperforming yet still reachable.
Catalog record
| CREATOR | Johannes Lauer, Julia Poppke, Thomas Nickl-Jockschat, Daniela C. Dieterich, Markus Fendt, Samia Afzal |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47145 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |